Clinical Trials List
Protocol NumberCOMB157G2399
Active
2019-03-28 - 2029-04-06
Phase III
Terminated1
ICD-10G35
Multiple sclerosis
ICD-9340
Multiple sclerosis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 謝函潔 Division of Neurology
- 林典佑 Division of Neurology
- Han-Wei Huang Division of Neurology
- Thy-Sheng Lin Division of Neurology
- Yuan-Ting Sun Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
2000 participants
